Imagine a vaccine that speeds up the production of antibodies against SARS-CoV-2, the virus that spreads COVID-19. A research team has developed such a vaccine by using preexisting immunity to a separate virus (the influenza virus) to help kickstart the process of making antibodies against SARS-CoV-2.